[1] |
Shin BS, Na CH, Song IG, et al. A case of human immunode⁃ficiency virus infection initially presented with disseminated herpes zoster[J]. Ann Dermatol, 2010, 22(2): 199⁃202. DOI: 10.5021/ad.2010.22.2.199.
|
[2] |
胡佳, 杨莉佳. 普瑞巴林治疗带状疱疹后遗神经痛[J]. 临床皮肤科杂志, 2013, 42(2): 126⁃127. DOI: 10.3969/j.issn.1000⁃4963.2013.02.031.
|
|
Hu J, Yang LJ. Pregabalin for the treatment of post⁃herpetic neuralgia[J]. J Clin Dermatol, 2013, 42(2): 126⁃127. DOI: 10.3969/j.issn.1000⁃4963.2013.02.031.
|
[3] |
Imafuku S, Nakayama J, Higa K, et al. One⁃year follow⁃up of zoster⁃associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study)[J]. J Eur Acad Dermatol Venereol, 2014, 28(12): 1716⁃1722.
|
[4] |
De Broucker T, Mailles A, Chabrier S, et al. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case⁃series of 20 patients[J]. Clin Microbiol Infect, 2012, 18(8): 808⁃819. DOI: 10.1111/j.1469⁃0691.2011.03705.x.
|
[5] |
刘蔚, 胡白, 赵政龙, 等. 播散性带状疱疹76例临床分析[J]. 中华皮肤科杂志, 2014, 47(1): 38⁃41. DOI: 10.3760/cma.j.issn. 0412⁃4030.2014.01.011.
|
|
Liu W, Hu B, Zhao ZL, et al. Clinical analysis of 76 cases of disseminated herpes zoster[J]. Chin J Dermatol, 2014, 47(1): 38⁃41. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.01.011.
|
[6] |
Takao Y, Miyazaki Y, Okeda M, et al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community⁃based prospective cohort study: the SHEZ study[J]. J Epidemiol, 2015, 25(10): 617⁃625. DOI: 10.2188/jea.je20140210.
|
[7] |
Hata A, Kuniyoshi M, Ohkusa Y. Risk of herpes zoster in patients with underlying diseases: a retrospective hospital⁃based cohort study[J]. Infection, 2011, 39(6): 537⁃544. DOI: 10.1007/s15010⁃011⁃0162⁃0.
|
[8] |
Iglar K, Kopp A, Glazier RH. Herpes zoster as a marker of underlying malignancy[J]. Open Med, 2013, 7(2): e68⁃e73.
|
[9] |
Suaya JA, Chen SY, Li Q, et al. Incidence of herpes zoster and persistent post⁃zoster pain in adults with or without diabetes in the United States[J]. Open Forum Infect Dis, 2014, 1(2): ofu049. DOI: 10.1093/ofid/ofu049.
|
[10] |
de Melker H, Berbers G, Hahné S, et al. The epidemiology of varicella and herpes zoster in the Netherlands: implications for varicella zoster virus vaccination[J]. Vaccine, 2006, 24(18): 3946⁃3952. DOI: 10.1016/j.vaccine.2006.02.017.
|
[11] |
Babamahmoodi F, Alikhani A, Ahangarkani F, et al. Clinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013[J]. Neurol Res Int, 2015, 2015: 896098. DOI: 10.1155/2015/896098.
|